Nitrito De Sodio Hope (Sodium Nitrite)

Nitrito De Sodio Hope is a nitrite antidote used in the management of cyanide toxicity.

• Cyanide poisoning: rapidly detoxifies cyanide by forming cyanmethemoglobin, helping restore cellular respiration.
• Acute cyanide exposure: provides emergency reversal of life‑threatening cyanide effects.
• Severe inhalational or ingestion cyanide incidents: supports critical care treatment protocols.

• Sodium nitrite oxidizes ferrous iron in hemoglobin to form methemoglobin. Methemoglobin has a high affinity for cyanide ions, creating cyanmethemoglobin, which sequesters cyanide and prevents it from inhibiting cytochrome oxidase, thereby restoring cellular oxidative metabolism.

Sodium nitrite may cause a range of adverse reactions, from mild to severe, depending on dose and patient factors.

Common Side Effects

• Methemoglobinemia: elevated methemoglobin levels causing cyanosis.
• Hypotension: transient drop in blood pressure after infusion.
• Nausea or vomiting: gastrointestinal discomfort.
• Headache: mild to moderate intensity.
• Dizziness or light‑headedness.

Serious or Rare Side Effects

• Severe methemoglobinemia: requiring emergency treatment with methylene blue.
• Hemolysis: especially in patients with G6PD deficiency.
• Anaphylactic or severe allergic reaction.
• Cardiovascular collapse: profound hypotension and shock.
• Respiratory distress: due to severe hypoxia.

Sodium nitrite should be administered only under controlled medical supervision with appropriate monitoring.

• Monitor methemoglobin levels: measure regularly during and after infusion.
• Use in a setting with resuscitation equipment: be prepared for rapid intervention.
• Adjust dosing in renal impairment: consider reduced clearance.
• Avoid in patients with known G6PD deficiency: risk of hemolysis.
• Contraindicated in hypersensitivity to nitrite compounds: discontinue immediately if reaction occurs.
• Store at ambient temperature: keep in original container, protect from moisture and light.

Sodium nitrite can interact with other agents that affect hemoglobin or vascular tone.

Major Interactions (Avoid)

• Concurrent oxidizing agents (e.g., methylene blue): may exacerbate methemoglobinemia.
• High‑dose nitrates: additive vasodilatory effects leading to severe hypotension.
• Certain anesthetic gases (e.g., nitrous oxide): increased risk of cyanide formation.

Moderate Interactions (Monitor Closely)

• Anticoagulants: monitor for bleeding as methemoglobin may affect platelet function.
• Antihypertensive drugs: watch for additive blood pressure lowering.
• Drugs influencing hemoglobin affinity (e.g., sulfonamides): may alter efficacy.